GSK

(Biotechnology, Medicine and Health)

Introduction

GSK is a company focused on health care. It has three world leading business that research, develop and produce medicines, vaccines and products for daily health care.

It operates in 150 countries forming a global team of 100,000 people, of which more than 10,000 are researchers.

Download Impulse to Business Development Programme (PIDE)'s file
GSK

Technology offer

Technical Specifications
  • Pharmaceutical Division: Development and production of drugs for the treatment of a large number of acute and chronic diseases. Leading company in the areas of Respiratory and HIV.
  • Rare Diseases: Development of innovative solutions for people affected by these diseases, such as amyloidosis, lysosomal diseases, primary immune deficiencies and pulmonary arterial hypertension.
  • R&D: In 2015 GSK allocated 3.100 million pounds to the research and development of new drugs and 52.6 million euros in Spain.
  • Vaccines: Leaders in vaccines thanks to the development, production and distribution of a wide portfolio of pediatric vaccines for adolescents, adults and travelers.
  • Consumer Healthcare: Development and commercialization of some of the most recognized and best-selling brands in the world for the control of pain, nutrition, and oral, digestive and dermatological health.
  • HIV: Global leadership through the company ViiV Healthcare, a global company specializing in HIV, of which GSK is a majority partner with Pfizer and Shionogi
  • Production: Through our 80 manufacturing plants, we serve clients from 190 countries. In Spain, the company has two production centers: Aranda del Duero (Burgos) and Alcalá de Henares (Madrid).

Contact information

Natalia Galeranatalia.m.galera@gsk.com